1,3,4 trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chains

This publication has 13 references indexed in Scilit:

• 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV
  Bioorganic & Medicinal Chemistry Letters, 2002
• Combinatorial synthesis of CCR5 antagonists
  Bioorganic & Medicinal Chemistry Letters, 2001
• Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist
  Journal of Medicinal Chemistry, 2001
• 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent Anti-HIV activity
  Bioorganic & Medicinal Chemistry Letters, 2001
• Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[N-(Methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes
  Bioorganic & Medicinal Chemistry Letters, 2001
• 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements
  Bioorganic & Medicinal Chemistry Letters, 2001
• A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
  Proceedings of the National Academy of Sciences, 1999
• Host factors and the pathogenesis of HIV-induced disease
  Nature, 1996
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
  Nature, 1996
• Identification of a major co-receptor for primary isolates of HIV-1
  Nature, 1996